CN1136909C - Liniment 'Rubikang' and its preparing process - Google Patents

Liniment 'Rubikang' and its preparing process Download PDF

Info

Publication number
CN1136909C
CN1136909C CNB021154945A CN02115494A CN1136909C CN 1136909 C CN1136909 C CN 1136909C CN B021154945 A CNB021154945 A CN B021154945A CN 02115494 A CN02115494 A CN 02115494A CN 1136909 C CN1136909 C CN 1136909C
Authority
CN
China
Prior art keywords
radix
medicine
breast
liniment
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021154945A
Other languages
Chinese (zh)
Other versions
CN1369308A (en
Inventor
郭朗轩
郭臻
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021154945A priority Critical patent/CN1136909C/en
Publication of CN1369308A publication Critical patent/CN1369308A/en
Application granted granted Critical
Publication of CN1136909C publication Critical patent/CN1136909C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a traditional Chinese medicine for treating gynecological breast diseases and a preparation method thereof. The traditional Chinese medicine has the key point that the traditional Chinese medicine is the external coating tincture which is prepared from Chinese angelica, hemlock parsley, white paeony root, trogopterus dung, dragon blood, notoginseng, cinnabar, frankincense, myrrh, borax, realgar, borneol, bezoar, musk, camphor, fructus, dahurian angelica root, red sage root, asarum herb and alcohol. The medicine has the functions for activating blood circulation to dissipate blood stasis, eliminating inflammation and relieving pains, and is mainly used for treating acute and chronic mastitis, hyperplasia of mammary glands, breast tumors, etc. The medicine has the advantages of peculiar and novel prescription, obvious treating effect, short treating course, convenient use, manifestation and root cause treatment, simplicity, convenience, low cost and effectiveness.

Description

A kind of liniment and compounding method for the treatment of mastopathy
The present invention relates to a kind of Chinese medicine and production method for the treatment of gynecological's mastopathy.
Mastopathy belongs to commonly encountered diseases and frequently-occurring disease in China, along with extensively carrying out of whole society's cystic hyperplasia of breast generaI investigation, the widespread usage of science auxiliary detection means, various mastotic recall rates are improved, especially the sickness rate of cyclomastopathy and mastocarcinoma has obvious ascendant trend, the numerous women's of serious threat health.And prior treatment method and effect of drugs are all undesirable.Particularly cyclomastopathy and breast tumor, except benign tumor can be with the excision, other is too effective way not.Though commercially available Western medicine and Chinese patent medicine also has certain effect at present, curative effect is long, and cure rate is not high.Therefore mastopathy becomes clinical difficult and complicated illness.
The purpose of this invention is to provide a kind of medicine and production method of new treatment mastopathy, it is made by pure Chinese medicine, have letter, just, test, characteristics such as honest and clean.
Nodules of the breast health liniment of the present invention is that the inventor's continuous processing improvement on proved recipe handed down from one's ancestors basis forms.It mainly comprises: Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Oletum Trogopterori, Sanguis Draxonis, Radix Notoginseng, Olibanum, Camphora, Borax, Realgar, Borneolum Syntheticum, Calculus Bovis, Moschus, Camphora, Fructus Zanthoxyli, the Radix Angelicae Dahuricae, Cinnabaris, Radix Salviae Miltiorrhizae, Herba Asari; and they are made tincture, be described in detail implementation procedure of the present invention below:
Medicine of the present invention comprises: Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Oletum Trogopterori, Sanguis Draxonis, Radix Notoginseng, Olibanum, Myrrha, Borax, Realgar, Borneolum Syntheticum, Calculus Bovis, Moschus, Camphora, Fructus Zanthoxyli, the Radix Angelicae Dahuricae, Cinnabaris, Radix Salviae Miltiorrhizae, Herba Asari.It is Radix Angelicae Sinensis 20-30 part, Rhizoma Chuanxiong 30-35 part, Radix Paeoniae Alba 25-30 part, Oletum Trogopterori 30-32 part, Sanguis Draxonis 27-30 part, Radix Notoginseng 3-5 part, Olibanum 40-50 part, Myrrha 42-45 part, Borax 25-32 part, Realgar 40-50 part, Borneolum Syntheticum 25-30 part, Calculus Bovis 3-10 part, Moschus 0.5-1 part, Camphora 10-15 part, Fructus Zanthoxyli 12-18 part, Radix Angelicae Dahuricae 20-22 part, Radix Salviae Miltiorrhizae 25-32 part, Herba Asari 10-15 part, Cinnabaris 8-13 part that medicine is formed.
Compound method of the present invention is:
Press the Chinese medicine preparation infusion process; getting the ethanol of 2500-3000 part 95% puts in the container; earlier Borneolum Syntheticum, Moschus, Calculus Bovis, Borax porphyrize are dissolved in the ethanol; remaining medicine Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Oletum Trogopterori, Sanguis Draxonis, Radix Notoginseng, Olibanum, Myrrha, Realgar, Camphora, Fructus Zanthoxyli, the Radix Angelicae Dahuricae, Cinnabaris, Radix Salviae Miltiorrhizae, Herba Asari are rolled into coarser powder also to be poured in the container of containing ethanol; be blended into 500-600 part distilled water again; airtight 20 days; every day, shake was 2-3 time; filtration is at last made and is contained the tincture of alcohol amount at 65%-70%, and it is standby to bottle.
Nodules of the breast health liniment of the present invention is made according to traditional Chinese medical science traditional theory, and the traditional Chinese medical science thinks that acute and chronic mastitis, cyclomastopathy, breast tumor etc. belong to the category of the traditional Chinese medical science " mastalgia ", " nodules of the breast ", and breast caking and mastalgia are its two big cardinal symptoms.Stagnation of QI due to depression of the liver, the turbid blood stasis of expectorant are tied mutually, malicious heresy is pented up then is the common pathologic basis of newborn illness.Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Oletum Trogopterori, Radix Salviae Miltiorrhizae, Sanguis Draxonis, Radix Notoginseng in " nodules of the breast health " liniment side of being drafted in view of the above have blood circulation promoting and blood stasis dispelling, depressed liver-energy dispersing and QI regulating, with the function of the pathogenic basis that disappears; Olibanum, Myrrha, Realgar, the Radix Angelicae Dahuricae have detoxicating and resolving stagnation of pathogens, and the eliminating carbuncle cellulitis hard pain that swells can be treated the cardinal symptom of breast disease; Borax, Calculus Bovis, Moschus, Borneolum Syntheticum, Camphora, Cinnabaris, detoxify, reduce phlegm fire, causing resuscitation with aromatic drugs, to ward off dirtyization turbid, can help detumescence, eliminating stagnation, pain relieving; Fructus Zanthoxyli, Herba Asari warming the meridian and cloudy eliminating stagnation.All medicines are harmonious, and play the merit of blood circulation promoting and blood stasis dispelling, detoxicating and resolving stagnation of pathogens, eliminating block and relieving pain altogether.Thereby to newborn portion inflammation illness, disease of hyperplasia of mammary glands glands, newborn portion tumors etc. all have good efficacy.Nodules of the breast health liniment, that is tincture by means of the effect of wine, have not only strengthened the power of invigorating blood circulation, and the transdermal that has more quickened medicine infiltrates, and it is faster stronger to play a role.
Nodules of the breast health liniment demonstrates its unique curative effect through the clinical verification more than 2 years.
Treatment acute and chronic mastitis (only for stasis of blood breast phase and chronic phase patient) 72 examples are observed, and wherein treat 36 examples with the nodules of the breast health, with antibiotic therapy 36 examples.As a result, with 11 examples that the treatment of nodules of the breast health was cured in 1-3 days, 18 examples of curing in 4-8 days.7 examples are only arranged more than chronic phase patient treatment 8-15 days.And use antibiotic therapy, all curing 6 examples of curing in 4-7 days, 8-15 days above 30 examples of curing more than 3 days.Find out that obviously nodules of the breast health treatment mastitis are better than antibiotic therapy.The acute mastitis of stasis of blood breast phase particularly is coated with the nodules of the breast health and puts on the skin several times, and the effect of pain relieving is at once all arranged.
Treatment cyclomastopathy (individual event or the multinomial hypertrophy that comprise lobules of mammary gland, acinus epithelium, latex dust, fibrous tissue).Observe treatment 110 examples, wherein women 105 examples, male 6 examples.Age is in 25-30 year person's 35 examples, 31-40 year person's 54 examples, 41-50 year person's 14 examples; Person's 8 examples more than 50 years old.Lump size: generally about about 3 * 3 centimetres and 3 * 5 centimetres.All case all is to confirm by sign and far infrared mammary diagnosis instrument.There are 60 routine patients singly to use nodules of the breast health liniment in the treatment, or cooperate the oral medicinal herb treatment as experimental group.There are 50 routine patients not use nodules of the breast health liniment treated, group in contrast, experimental group clinical cure 49 examples as a result, effective (containing produce effects) 11 examples, cure rate is 80.1%, total effective rate is 100%.Do not use the matched group of nodules of the breast health, clinical cure 28 examples, effective 13 examples, invalid 9 examples, its cure rate is 56%, total effective rate is 78%.Simultaneously, obvious with nodules of the breast health treatment analgesic effect, generally got final product pain relieving in 1-2 days.With nodules of the breast health treatment breast benign tumor (comprising mammary gland fibroadenoma, cyst of breast etc.) clinical observation treatment 30 examples, effective 18 examples of clinical cure 10 examples (disappearance of tumor body) as a result, (the tumor body dwindles 1/3), invalid 2 examples, total effective rate is 93.3%, makes the patient exempt the hardship of operation.
Breast carcinoma is to rise in the malignant tumor of breast duct and lobule epithelial tissue.Use the nodules of the breast health and observe treatment 20 routine breast carcinoma initial stage patients, all can reach the purpose of pain relieving and lump deliquescing, the state of an illness is stablized.Its pain relieving total effective rate is 100%, and lump uses 8 examples of deliquescing after 10 days, and 5 examples that lump dwindles have and significantly control the cancer cancer resistant effect.
Clinical trial certificate for many years: nodules of the breast health liniment all has the pain relieving cancer resistant effect to multiple carninomatosis, to various local inflammations, pain relieving and antiinflammation is arranged all.
Good effect of the present invention is: the prescription novelty, and uniqueness, short treating period, evident in efficacy, without any side effects, easy to use, low price has characteristics easy, honest and clean, effect, is specially adapted to breast inflammation and mammary neoplasms patient and uses.

Claims (2)

1. the liniment of treatment mastopathy is characterized in that it is to add the tincture that ethanol is made by following proportion raw material by weight: Radix Angelicae Sinensis 20-30 part, Rhizoma Chuanxiong 30-35 part, Radix Paeoniae Alba 25-30 part, Oletum Trogopterori 30-32 part, Resina Draconis 27-30 part, Radix Notoginseng 3-5 part, Olibanum 40-50 part, Myrrha 42-45 part, Borax 25-32 part, Realgar 40-50 part, Borneolum Syntheticum 25-30 part, Calculus Bovis 3-10 part, Moschus 0.5-1 part, Camphora 10-15 part, Fructus Zanthoxyli 12-18 part, Radix Angelicae Dahuricae 20-22 part, Cinnabaris 8-13 part, Radix Salviae Miltiorrhizae 25-32 part, Herba Asari 10-15 part.
2. the preparation method of the liniment of the described treatment mastopathy of claim 1; it is characterized in that the ethanol of getting 2500-3000 part 95% puts in the container; earlier with Borneolum Syntheticum; Moschus; Calculus Bovis; the Borax porphyrize is dissolved in the ethanol; with medicine Radix Angelicae Sinensis wherein; Rhizoma Chuanxiong; the Radix Paeoniae Alba; Oletum Trogopterori; Resina Draconis; Radix Notoginseng; Olibanum; Myrrha; Realgar; Camphora; Fructus Zanthoxyli; the Radix Angelicae Dahuricae; Cinnabaris; Radix Salviae Miltiorrhizae; Herba Asari rolls into coarser powder and also pours in the container of containing ethanol; be blended into 500-600 part distilled water again; airtight 20 days; every day, shake was 2-3 time; filtration is at last made and is contained the tincture of alcohol amount at 65%-70%, and bottling gets final product.
CNB021154945A 2002-01-27 2002-01-27 Liniment 'Rubikang' and its preparing process Expired - Fee Related CN1136909C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021154945A CN1136909C (en) 2002-01-27 2002-01-27 Liniment 'Rubikang' and its preparing process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021154945A CN1136909C (en) 2002-01-27 2002-01-27 Liniment 'Rubikang' and its preparing process

Publications (2)

Publication Number Publication Date
CN1369308A CN1369308A (en) 2002-09-18
CN1136909C true CN1136909C (en) 2004-02-04

Family

ID=4743690

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021154945A Expired - Fee Related CN1136909C (en) 2002-01-27 2002-01-27 Liniment 'Rubikang' and its preparing process

Country Status (1)

Country Link
CN (1) CN1136909C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101041015B (en) * 2007-04-19 2011-05-18 韩曙光 Medicine for treating hyperplasia of mammary glands

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1310653C (en) * 2003-07-04 2007-04-18 孙玉环 Externally used medicine for tracheitis and cough
CN1294929C (en) * 2005-05-10 2007-01-17 薛魁博 Medication for treating milk sicknss and preparation method
CN105903002A (en) * 2016-06-17 2016-08-31 孙和平 Emulsion for eliminating breast distending pain and breast nodules and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101041015B (en) * 2007-04-19 2011-05-18 韩曙光 Medicine for treating hyperplasia of mammary glands

Also Published As

Publication number Publication date
CN1369308A (en) 2002-09-18

Similar Documents

Publication Publication Date Title
CN101919927B (en) Spray for promoting scald healing
CN1136909C (en) Liniment 'Rubikang' and its preparing process
CN102872283A (en) Traditional Chinese medicine composition for treating bone fracture
CN100998637B (en) Traditional Chinese medicine for treating bone tuberculosis and arthritis
CN100369626C (en) Traditional Chinese medicine capsule for treating mammary gland diseases
CN101229234A (en) Face-sterilizing powdered medicine
CN103083387A (en) Congestion-eliminating pain-relieving plaster
CN103230535A (en) Medicinal liquor with function of activating collaterals to ease pain
CN1223132A (en) Medicine for curing dermatosis
CN112691147A (en) Traditional Chinese medicine composition for treating shoulder pain after stroke, external medicine and preparation method thereof
CN101810668A (en) Toxin drawing plaster
CN105770796A (en) Medicinal liquor liniment for treating soft tissue injury
CN104491511A (en) Traditional Chinese medicine external-applying preparation for treating hyperplasia of mammary glands
CN105311559A (en) Medicinal liquor for treating scapulohumeral periarthritis
CN105267703A (en) Traditional Chinese medicine for treating cervical spondylosis
CN1823927A (en) Medicine for treating proliferation of mammary gland
CN102614330A (en) Medicinal liquor for treating rheumatic arthritis
CN101554461B (en) Medicine for treating psoriasis and preparation method of capsule thereof
CN101361889A (en) Traditional Chinese medicine capsule for treating psoriasis
CN105031545A (en) Orally taken traditional Chinese medicine for treating hyperplasia of mammary glands
CN1320911C (en) Externally applied powder for treating skin and external diseases, skin gall
CN103028049A (en) Traditional Chinese medicine composition for treating tinea manuum and preparation method of composition
CN103006776A (en) Traditional Chinese medicine for treating wry mouth and tropia caused by facial nerve paralysis caused by cold
CN111358838A (en) A topical Chinese medicinal ointment with effects of relaxing muscles and tendons, promoting blood circulation, and dredging channels and collaterals
CN103156909B (en) Chinese medicine composition for curing osteoproliferation and preparing method thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040204

Termination date: 20100301